Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4300233 | 1.00 | GSR (0.46) | GSRRNPEPCPB2NOD1GRIK1 | |
| SCHEMBL9634474 | 0.90 | NOD1 (0.49) | GSRRNPEPCPB2NOD1GRIK1 | |
| SCHEMBL9634471 | 0.90 | NOD1 (0.49) | GSRRNPEPCPB2NOD1GRIK1 | |
| SCHEMBL30775015 | 0.88 | NOD1 (0.51) | GSRCPB2NOD1GRIK1GRIK2 | |
| SCHEMBL341674 | 0.88 | NOD1 (0.51) | GSRCPB2NOD1GRIK1GRIK2 | |
| SCHEMBL1031164 | 0.88 | NOD1 (0.51) | GSRCPB2NOD1GRIK1GRIK2 | |
| SCHEMBL28077042 | 0.88 | NOD1 (0.51) | GSRCPB2NOD1GRIK1GRIK2 | |
| SCHEMBL6859337 | 0.87 | GSR (0.50) | GSRRNPEPCPB2NOD1FOLH1 | |
| SCHEMBL6859332 | 0.87 | GSR (0.50) | GSRRNPEPCPB2NOD1FOLH1 | |
| SCHEMBL9062119 | 0.86 | NOD1 (0.49) | GSRCPB2NOD1GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117355321-A | Performance enhancing excipients and methods for reducing viscosity and improving stability of biological agents | 安万托特性材料股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20090264618-A1 | Compounds With a Branched Linker | ANDRES HERBERT | 2009-10-22 | — | — | US | disclosed |
| EP-1327146-B1 | COMPOUNDS WITH A BRANCHED LINKER | ROCHE DIAGNOSTICS GMBH (DE) | 2005-09-14 | — | — | EP | disclosed |
| US-20040086943-A1 | Coupling agent containing secordary amide groups | ROCHE DIAGNOSTICS OPERATIONS, INC. | 2004-05-06 | — | — | US | disclosed |
| EP-1327146-A2 | COMPOUNDS WITH A BRANCHED LINKER | Roche Diagnostics GmbH (DE) | 2003-07-16 | — | — | EP | disclosed |
| WO-2002027315-A2 | COMPOUNDS WITH A BRANCHED LINKER | ROCHE DIAGNOSTICS GMBH (DE) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264618-A1 | Compounds With a Branched Linker | ZYX, ZFX, BMX | GSR 2547/4885RNPEP 490/4885CPB2 1305/4885 |
| US-20040086943-A1 | Coupling agent containing secordary amide groups | PAICS, BRDT, ERBB2 | GSR 3250/4885RNPEP 689/4885CPB2 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.